FONAR Corporation Inc (FONR) - Rasio tanggungan utang jangka dawa marang modal

FONAR Corporation - logo grafis emiten FONR

FONAR Corporation is renowned for developing exclusive vertical MRI scanners, as evidenced by the long-term debt-to-equity ratio dynamics. The value 0.18 serves as the current parameter value. Business revenues rely on equipment sales and the operation of its own diagnostic centers. Simultaneously, the company is implementing ESG standards, improving system energy efficiency and utilizing eco-friendly component packaging.

FONAR (FONR): Utang jangka dawa marang modal saka 04.07.2022 nganti 13.06.2026
Sampel barang FONAR Corp

This indicator determines the volume of credit leverage through the ratio of liabilities with a maturity of over one year to equity. The formula measures the degree of the business's financial autonomy and its dependence on external borrowings. By analyzing the long-term debt-to-equity ratio, an investor assesses solvency risks. A low leverage level confirms the conservative approach of FONAR Corporation (FONR) management. This reflects a slow-growth strategy and a priority on stability within the diagnostic services niche.

Perusahaan pesaing

Rasio utang jangka dawa marang modal ABT (Abbott Labs)|Utang jangka dawa marang modal TMO|Rasio tanggungan utang jangka dawa marang modal GE HealthCare Inc.|Utang jangka dawa marang modal MTD (Mettler-Toledo International)|Utang jangka dawa marang modal waters.com WAT|Bio-Techne - Utang jangka dawa marang modal|Tanggungan utang jangka dawa marang ekuitas Bruker Corp (BRKR)|Azenta Life Sciences (AZTA) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang modal VREX|Utang jangka dawa marang ekuitas Semler Scientific, Inc.|Kewajiban jangka dawa marang modal butterflynetwork.com BFLY|Utang jangka dawa marang ekuitas Mesa Labs (MLAB)|Rasio tanggungan utang jangka dawa marang modal Quantum-Si Inc.|Nanox - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka dawa marang modal QTRX (Quanterix Inc)|908 Devices Inc. - Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal CapsoVision Inc CV|MXCT: Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas Rapid Micro Biosystems, Inc.|Rasio utang jangka dawa marang ekuitas SEER|HYPR: Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Daxor Corporation (DXR)|Rasio utang jangka dawa marang ekuitas Spectral AI Inc. MDAI|Utang jangka dawa marang modal VIVS (Organovo Holdings, Inc.)|Aclarion Inc (ACON) - Kewajiban jangka dawa marang modal|Akoya - Utang jangka dawa marang modal|THMO (Cesca Therapeutics) - Rasio utang jangka dawa marang modal|TLIS: Utang jangka dawa marang modal|TTOO - Rasio tanggungan utang jangka dawa marang modal